title: [Cancer immunotherapy: new approaches].
authors.affiliation: Unité Inserm 453, Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon et Unité d'oncologie médicale, hôpital édouard-Herriot, place d'Arsonval, 69003 Lyon.
authors.forename: J Y
authors.initials: JY
authors.lastname: Blay
authors.forename: M C
authors.initials: MC
authors.lastname: Thomachot
authors.forename: L
authors.initials: L
authors.lastname: Alberti
authors.forename: T
authors.initials: T
authors.lastname: Bachelot
authors.forename: N
authors.initials: N
authors.lastname: Voorzanger-Rousselot
authors.forename: I
authors.initials: I
authors.lastname: Puisieux
authors.forename: L
authors.initials: L
authors.lastname: Odin
authors.forename: C
authors.initials: C
authors.lastname: Ménétrier-Caux
mesh_terms: D019496:Cancer Vaccines / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive / Q000379:methods; D007167:Immunotherapy / Q000379:methods*; D007372:Interferons / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D019860:Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000637:transplantation*
chemical_list: D019496:Cancer Vaccines; D007376:Interleukin-2; D009363:Neoplasm Proteins; D007372:Interferons; D019860:Lymphocyte Specific Protein Tyrosine Kinase p56(lck)